In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Guardian Pharmacy Services Inc (NYSE: GRDN) closed at $20.33 down -1.55% from its previous closing price of $20.65. In other words, the price has decreased by -$1.55 from its previous closing price. On the day, 0.58 million shares were traded. GRDN stock price reached its highest trading level at $20.965 during the session, while it also had its lowest trading level at $19.82.
Ratios:
For a deeper understanding of Guardian Pharmacy Services Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 93.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.20. For the most recent quarter (mrq), Quick Ratio is recorded 0.84 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.14.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on October 21, 2024, initiated with a Buy rating and assigned the stock a target price of $22.
On October 21, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $21.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 27 ’25 when BINDLEY WILLIAM E sold 3,508,905 shares for $20.16 per share. The transaction valued at 70,739,525 led to the insider holds 2,591,271 shares of the business.
BINDLEY WILLIAM E sold 651,454 shares of GRDN for $13,133,313 on May 28 ’25. The Director now owns 1,939,817 shares after completing the transaction at $20.16 per share. On May 27 ’25, another insider, Salentine Thomas J Jr, who serves as the Director of the company, sold 3,508,905 shares for $20.16 each. As a result, the insider received 70,739,525 and left with 2,591,271 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GRDN now has a Market Capitalization of 1306869376 and an Enterprise Value of 1311902464. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.03 while its Price-to-Book (P/B) ratio in mrq is 8.24. Its current Enterprise Value per Revenue stands at 1.023 whereas that against EBITDA is -37.143.
Stock Price History:
Over the past 52 weeks, GRDN has reached a high of $26.91, while it has fallen to a 52-week low of $14.16. The 50-Day Moving Average of the stock is -12.02%, while the 200-Day Moving Average is calculated to be -4.29%.
Shares Statistics:
For the past three months, GRDN has traded an average of 185.18K shares per day and 420550 over the past ten days. A total of 22.72M shares are outstanding, with a floating share count of 20.49M. Insiders hold about 68.34% of the company’s shares, while institutions hold 15.22% stake in the company. Shares short for GRDN as of 1747267200 were 955967 with a Short Ratio of 5.16, compared to 1744675200 on 987972. Therefore, it implies a Short% of Shares Outstanding of 955967 and a Short% of Float of 7.59.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of Guardian Pharmacy Services Inc (GRDN) is currently being evaluated by 2 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is $0.23, with high estimates of $0.24 and low estimates of $0.23.
Analysts are recommending an EPS of between $0.92 and $0.88 for the fiscal current year, implying an average EPS of $0.9. EPS for the following year is $1.05, with 2.0 analysts recommending between $1.08 and $1.02.
Revenue Estimates
For the next quarter, 2 analysts are estimating revenue of $336.64M. There is a high estimate of $336.8M for the next quarter, whereas the lowest estimate is $336.48M.
A total of 2 analysts have provided revenue estimates for GRDN’s current fiscal year. The highest revenue estimate was $1.35B, while the lowest revenue estimate was $1.35B, resulting in an average revenue estimate of $1.35B. In the same quarter a year ago, actual revenue was $1.23BBased on 2 analysts’ estimates, the company’s revenue will be $1.38B in the next fiscal year. The high estimate is $1.39B and the low estimate is $1.38B.
